Controversy arises over illegal rebates made by Company A
By Nho, Byung Chul | translator Kim, Jung-Ju
23.10.16 05:50:34
가나다라
0
Expediently used corporate credit cards under implicit approval from the CEO
Made illegal cash-back transactions using credit cards and provided expensive groceries to prescribing doctors
The same company that had received administrative action and sales suspension dispositions for the same issue 10 years ago
The multinational pharmaceutical company A's illegal rebate activities have gone too far and are disrupting competition in relevant markets.
According to an anonymous tip on the 15th, Company A has been providing economic benefits to prescribers at large general hospitals to promote drug sales.
The same company was investigated by the Fair Trade Commission and the police around 10 years ago, and the Ministry of Food and Drug Safety imposed a fine for related products at the time.
Company A owns several global blockbuster products, and although relatively inexpensive latecomer generics have been released for many of their blockbusters, the company’s performance imp
Nho, Byung Chul(sasiman@dailypharm.com)
If you want to see the full article, please JOIN US (click)